158 related articles for article (PubMed ID: 25468041)
1. Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.
Wada S; Urase T; Hasegawa Y; Ban K; Sudani A; Kawai Y; Hayashi J; Urata H
Bioorg Med Chem; 2014 Dec; 22(24):6776-80. PubMed ID: 25468041
[TBL] [Abstract][Full Text] [Related]
2. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.
Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H
Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake of Aib-containing amphipathic helix peptide.
Wada S; Tsuda H; Okada T; Urata H
Bioorg Med Chem Lett; 2011 Oct; 21(19):5688-91. PubMed ID: 21875799
[TBL] [Abstract][Full Text] [Related]
4. Translocation of an Aib-containing peptide through cell membranes.
Wada S; Hitora Y; Tanaka R; Urata H
Bioorg Med Chem Lett; 2008 Jul; 18(14):3999-4001. PubMed ID: 18565748
[TBL] [Abstract][Full Text] [Related]
5. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
6. Cellular uptake of covalent conjugates of oligonucleotide with membrane-modifying peptide, peptaibol.
Wada S; Hitora Y; Yokoe S; Nakagawa O; Urata H
Bioorg Med Chem; 2012 May; 20(10):3219-22. PubMed ID: 22525495
[TBL] [Abstract][Full Text] [Related]
7. α-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide-Cyclic RGD Conjugation as a Potential Drug Delivery System for MicroRNA Replacement Therapy in Vitro.
Taniguchi K; Wada SI; Ito Y; Hayashi J; Inomata Y; Lee SW; Tanaka T; Komura K; Akao Y; Urata H; Uchiyama K
Mol Pharm; 2019 Nov; 16(11):4542-4550. PubMed ID: 31596588
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
Guterstam P; Andaloussi SE; Langel U
Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
[TBL] [Abstract][Full Text] [Related]
10. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
Grijalvo S; Terrazas M; Aviñó A; Eritja R
Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
[TBL] [Abstract][Full Text] [Related]
11. Development of 2-aminoisobutyric acid (Aib)-rich cell-penetrating foldamers for efficient siRNA delivery.
Misawa T; Ohoka N; Oba M; Yamashita H; Tanaka M; Naito M; Demizu Y
Chem Commun (Camb); 2019 Jul; 55(54):7792-7795. PubMed ID: 31210205
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
[TBL] [Abstract][Full Text] [Related]
13. Enhanced protein thermostability by Ala-->Aib replacement.
De Filippis V; De Antoni F; Frigo M; Polverino de Laureto P; Fontana A
Biochemistry; 1998 Feb; 37(6):1686-96. PubMed ID: 9484240
[TBL] [Abstract][Full Text] [Related]
14. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
15. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship study of Aib-containing amphipathic helical peptide-cyclic RGD conjugates as carriers for siRNA delivery.
Wada SI; Takesada A; Nagamura Y; Sogabe E; Ohki R; Hayashi J; Urata H
Bioorg Med Chem Lett; 2017 Dec; 27(24):5378-5381. PubMed ID: 29157863
[TBL] [Abstract][Full Text] [Related]
17. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
El Andaloussi S; Said Hassane F; Boisguerin P; Sillard R; Langel U; Lebleu B
Methods Mol Biol; 2011; 764():75-89. PubMed ID: 21748634
[TBL] [Abstract][Full Text] [Related]
19. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
Andaloussi SE; Lehto T; Lundin P; Langel U
Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
[TBL] [Abstract][Full Text] [Related]
20. Conformational preferences of a short Aib/Ala-based water-soluble peptide as a function of temperature.
Banerjee R; Chattopadhyay S; Basu G
Proteins; 2009 Jul; 76(1):184-200. PubMed ID: 19137603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
